期刊文献+

丙型肝炎病毒F蛋白诱导LX2肝星形细胞活化

Activation of hepatic stellate LX2 cells by F protein of hepatitis C virus
下载PDF
导出
摘要 目的探讨丙型肝炎病毒(HCV)F蛋白对肝星形细胞(HSC)功能的影响。方法采用脂质体转染法将pcDNA3.1-f(实验组)或pcDNA3.1空质粒(对照组)转染HSC株LX2细胞,24、48 h后收集细胞,用Western blot法检测α-肌动蛋白(α-SMA)含量,RT-PCR法测定金属蛋白酶组织抑制因子1(TI MP-1)和基质金属蛋白酶2(MMP-2)基因mRNA表达水平。结果转染后24、48 h,实验组LX2细胞α-SMA蛋白表达量以及TI MP-1基因mRNA水平均明显高于对照组,两组细胞MMP-2基因mRNA水平接近。结论 HCV F蛋白能够活化HSC,上调其TI MP-1基因转录水平,但不影响MMP-2基因转录水平,使MMP-2蛋白的有效酶活性下降,造成肝组织细胞外基质(ECM)降解速率减慢,进而发生纤维化。 Objective To investigate the effect of hepatitis C virus(HCV) F protein on function of hepatic stellate cells.Methods 24 h and 48 h after transfection pcDNA3.1-f(test group)or pcDNA3.1(control group) plasmid into hepatic stellate LX2 cells by liposome,the protein of smooth muscle α-actin(α-SMA) was detected by Western blot,and the mRNA level of tissue inhibitor factor 1 of metalloproteinases(TIMP-1) and matrix metalloproteinase 2(MMP-2) gene were examined by RT-PCR.Results 24 h and 48 h after LX2 cells transfected pcDNA3.1-f(test group) or pcDNA3.1(control group),the content of α-SMA protein and the mRNA level of TIMP-1 gene of cells in test group was high than that in control group,and the mRNA level of MMP-2 gene of cells showed no difference between test and control groups.Conclusion HCV F protein is able to activate hepatic stellate LX2 cells,enhance the mRNA level of TIMP-1 gene,but not affect MMP-2 gene transcription,which make the effective enzyme activity of MMP-2 protein be decreased,the degradation rate of ECM in hepatic tissue slowed down,and result in hepatic fibrosis.
出处 《重庆医学》 CAS CSCD 北大核心 2011年第9期883-885,共3页 Chongqing medicine
基金 湖州市自然科学基金资助项目(2008YZ05)
关键词 肝炎病毒属 肝细胞 金属蛋白酶类组织抑制剂 金属蛋白酶类 hepacivirus hepatocytes tissue inhibitor of metalloproteinases metalloproteases
  • 相关文献

参考文献15

  • 1丙型肝炎防治指南[J].临床肝胆病杂志,2004,20(4):197-203. 被引量:735
  • 2Lonardo A, Loria P, Adinolfi LE, et al. Hepatitis C and steatosis:a reappraisal[J]. J Viral Hepat, 2006, 13 (2):73-80.
  • 3Xu Z,Choi J,Yen TS, et al. Synthesis of a novel hepatitis C virus protein by ribosomal frameshift[J]. EMBO J, 2001,20(14): 8840-3848.
  • 4Xu Z,Choi J,Lu W,et al. Hepatitis C virus f protein is a short:lived protein associated with the endoplasmic reticulum[J]. J Virol, 2003,77(2) : 1578-1583.
  • 5Branch AD,Walewski JL, Gutierrez JA, et al. The hepatitis C virus alternate reading frame(ARF) and its family of novel products:the alternate reading frame protein/Fprotein, the double-frameshift protein, and others [J]. Semin Liver Dis,2005,25(1):105-117.
  • 6周伟,沈薇.肝细胞生长因子对肝纤维化的保护作用及其机制研究[J].重庆医学,2009,38(4):398-400. 被引量:10
  • 7Son G, Hines IN, Lindquist J, et al. Inhibition of phos phatidylinositol 3-kinase signaling in hepatic stellate cells blocks the progression of hepatic fibrosis[J]. Hepatology,2009,50(5) :1512-1523.
  • 8Perugorria MJ, Latasa MU, Nicou A, et al. The epidermal growth factor receptor ligand amphiregulin participates in the development of mouse liver fibrosis[J]. Hepatology, 2008,48(4) :1251-1261.
  • 9Guo J,Friedman Sir. Hepatic fibrogenesis[J]. Semin laver Dis,2007,27(4):413-426.
  • 10Han YP,Yan C, Zhou L, et al. A matrix metalloproteinase-9 activation cascade by hepatic stellate cells in trans differ entiation in the three-dimensional extracellular matrix [J]. J Biol Chem,2007,282(17) :12928-12939.

二级参考文献21

  • 1周伟,沈薇.肝细胞增殖、凋亡与肝纤维化关系的实验研究[J].重庆医学,2007,36(11):1062-1064. 被引量:19
  • 2Matsuda Y, Matsurnoto K, Yamada A, et al. Preventive and therapeutic effects in rats of hepatocyte growth factor infusion on liver fibrosis/cirrhosis[J]. Hepatology, 1997, 26(1):81.
  • 3Friedman SL. Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis,mechanisms and treatment strategives[J]. N Engl J Med, 1998,328(25) : 1828.
  • 4Masunaga H, Fujise N, Shiota A. Preventive effects of the deleted form of hepatocyte growth factor against various liver injuries[J]. Eur J Pharmacol, 1998,342(2-3) : 26.
  • 5Crusch M, Polgar D, Gfatler S, et al. Maintenance of ATP favours apoptosis over necrosis triggered by benzamide riboside[J]. Cell Death Difer,2002,9(2) : 169.
  • 6Roucou X, Rostovtseva T, Montessit S, et al. Bid induces cytochrome c-imemeable bax channels in liposomes[J]. Biochem,2002,363(Pt 3) :547.
  • 7Camma C, Bruno S, Schepis F, et al. Retreatment with interferon plus ribavirin of chronic hepatitis C non- responders to interferon monotherapy: a meta- analysis of individual patient data[ J ]. Gut, 2002,51:864-869.
  • 8Papatheodoridis GV, Papadimitropoulos VC, Hsdziyannis SJ. Effect of interferon therapy on the development of hepatocellular carcinoma in patients with hepatitis C virus- reated cirrhosis: a meta- analysis[J] .Aliment Pnarmaool Ther, 2001,15:689- 698.
  • 9Kjaergard LL, Krogsgaard K, Gluud C. Interfern alfa with or without ribavirin for chronic hepatitis C: systematic review of randonmised trials[J].BMJ, 2001,323:1151 - 1155.
  • 10Alberti A, Benvegnu L. Management of hepatitis[J] .J Hepatol, 2003,38(Suppl1): S1014 - S1 18.

共引文献743

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部